Skip to main content

Travere Therapeutics, Inc 10-Q for FY2024 Q1

Travere Therapeutics, Inc. (TVTX)

10-Q 2024-05-06 For: 2024-03-31
View Original
Added on April 07, 2026

About this 10-Q

Travere Therapeutics, Inc filed this 10-Q on May 6, 2024, covering the quarter ended March 31, 2024 (FY2024 Q1).

Headline figures

Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$41.37M
up 33.9% from $30.89M a year earlier
Net loss
$136.06M
compared with a net loss of $86.33M a year earlier
Diluted EPS
-$1.76
compared with -$1.27 a year earlier